SG11202013218QA - Biaryl ether-type quinazoline derivatives - Google Patents

Biaryl ether-type quinazoline derivatives

Info

Publication number
SG11202013218QA
SG11202013218QA SG11202013218QA SG11202013218QA SG11202013218QA SG 11202013218Q A SG11202013218Q A SG 11202013218QA SG 11202013218Q A SG11202013218Q A SG 11202013218QA SG 11202013218Q A SG11202013218Q A SG 11202013218QA SG 11202013218Q A SG11202013218Q A SG 11202013218QA
Authority
SG
Singapore
Prior art keywords
type
quinazoline derivatives
biaryl ether
biaryl
ether
Prior art date
Application number
SG11202013218QA
Other languages
English (en)
Inventor
Kenichi Yoshida
Kosuke Takeuchi
Hidekazu Inoue
Hideaki Kageji
Takayuki Momose
Keisuke Yoshida
Takeshi Jimbo
Akiko Egami
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of SG11202013218QA publication Critical patent/SG11202013218QA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/94—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
SG11202013218QA 2018-07-04 2019-07-03 Biaryl ether-type quinazoline derivatives SG11202013218QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018127829 2018-07-04
PCT/JP2019/026483 WO2020009156A1 (ja) 2018-07-04 2019-07-03 ビアリールエーテル型キナゾリン誘導体

Publications (1)

Publication Number Publication Date
SG11202013218QA true SG11202013218QA (en) 2021-02-25

Family

ID=69059535

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202013218QA SG11202013218QA (en) 2018-07-04 2019-07-03 Biaryl ether-type quinazoline derivatives

Country Status (15)

Country Link
US (1) US20230025510A1 (zh)
EP (1) EP3822263A4 (zh)
JP (1) JP7288904B2 (zh)
KR (1) KR20210029165A (zh)
CN (1) CN112334460A (zh)
AU (1) AU2019297889A1 (zh)
BR (1) BR112020027064A2 (zh)
CA (1) CA3105602A1 (zh)
CO (1) CO2021000800A2 (zh)
IL (1) IL279858A (zh)
MX (1) MX2021000014A (zh)
PH (1) PH12021550003A1 (zh)
SG (1) SG11202013218QA (zh)
TW (1) TW202012391A (zh)
WO (1) WO2020009156A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020262998A1 (ko) * 2019-06-26 2020-12-30 한미약품 주식회사 항 종양 활성을 갖는 신규 퀴나졸린 유도체 및 이를 포함하는 약학 조성물
JP7449028B2 (ja) * 2020-08-10 2024-03-13 上海和誉生物医薬科技有限公司 Ｅｇｆｒ阻害剤およびその製造方法と応用
WO2022105908A1 (zh) * 2020-11-23 2022-05-27 上海和誉生物医药科技有限公司 Egfr抑制剂及其制备方法与在药学上的应用
CN113264888A (zh) * 2021-03-04 2021-08-17 江苏康可得生物技术股份有限公司 酪氨酸激酶抑制剂及其药物应用
TW202404590A (zh) * 2022-04-05 2024-02-01 美商纜圖藥品公司 Ｅｇｆｒ抑制劑
CN117384162A (zh) * 2022-05-17 2024-01-12 浙江文达医药科技有限公司 选择性her2抑制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69710712T3 (de) * 1996-04-12 2010-12-23 Warner-Lambert Co. Llc Umkehrbare inhibitoren von tyrosin kinasen
CA2527017A1 (en) * 2003-05-27 2004-12-09 Pfizer Products Inc. Quinazolines and pyrido [3,4-d] pyrimidines as receptor tyrosine kinase inhibitors
TWI377944B (en) * 2007-06-05 2012-12-01 Hanmi Holdings Co Ltd Novel amide derivative for inhibiting the growth of cancer cells
CN104736155B (zh) * 2012-05-14 2018-01-02 杭州德润玉成生物科技有限公司 双环化合物作为激酶的抑制剂
CN103965120B (zh) * 2013-01-25 2016-08-17 上海医药集团股份有限公司 喹啉及喹唑啉衍生物、制备方法、中间体、组合物及应用
AU2017363199B2 (en) * 2016-11-17 2023-08-17 Board Of Regents, The University Of Texas System Compounds with anti-tumor activity against cancer cells bearing EGFR or HER2 exon 20 mutations
WO2020262998A1 (ko) * 2019-06-26 2020-12-30 한미약품 주식회사 항 종양 활성을 갖는 신규 퀴나졸린 유도체 및 이를 포함하는 약학 조성물

Also Published As

Publication number Publication date
WO2020009156A1 (ja) 2020-01-09
CN112334460A (zh) 2021-02-05
PH12021550003A1 (en) 2021-09-20
JP7288904B2 (ja) 2023-06-08
EP3822263A4 (en) 2022-03-16
AU2019297889A1 (en) 2021-02-18
BR112020027064A2 (pt) 2021-05-25
KR20210029165A (ko) 2021-03-15
TW202012391A (zh) 2020-04-01
CO2021000800A2 (es) 2021-02-08
MX2021000014A (es) 2021-03-09
IL279858A (en) 2021-03-01
EP3822263A1 (en) 2021-05-19
US20230025510A1 (en) 2023-01-26
CA3105602A1 (en) 2020-01-09
JPWO2020009156A1 (ja) 2021-07-15

Similar Documents

Publication Publication Date Title
IL279858A (en) Biaryl ether type quinazoline derivatives
CA185743S (en) Step system
ZA202102135B (en) Concrete forming system
GB201909535D0 (en) Extension paint spray-roller system
GB2578257B (en) Set on demand cement
GB202003767D0 (en) Mult-zone actualtion system using wellbore darts
GB201720056D0 (en) Systems and methods for providing meal plans
HK1254131A1 (zh) 打印系統和相關方法
IL277581A (en) Size measurement system
GB2574246B (en) Tile system
GB201720049D0 (en) Systems and methods for providing meal plans
GB2573634B (en) Shade system
EP3623755C0 (en) RULE
GB201609032D0 (en) Levelling systems and methods
GB2569872B (en) Instance usage facilitating system
GB2535506B (en) Retractable blind system
PL3676551T3 (pl) Kalcynator o niskiej emisji nox
IL279519A (en) sensing systems
GB2558827B (en) Cementing indication systems
GB2580512B (en) System
GB201818757D0 (en) Shower-screen retraction system
DK3767166T3 (en) Optisk system
EP4039908C0 (en) PRECISION TILE LAYING SYSTEM
GB201707669D0 (en) Paint system
SG11202105198XA (en) Wireless electronic-control system